Correlation Between LIFE Old and Lyra Therapeutics
Can any of the company-specific risk be diversified away by investing in both LIFE Old and Lyra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LIFE Old and Lyra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between LIFE Old and Lyra Therapeutics, you can compare the effects of market volatilities on LIFE Old and Lyra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LIFE Old with a short position of Lyra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of LIFE Old and Lyra Therapeutics.
Diversification Opportunities for LIFE Old and Lyra Therapeutics
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between LIFE and Lyra is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding LIFE Old and Lyra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyra Therapeutics and LIFE Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LIFE Old are associated (or correlated) with Lyra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyra Therapeutics has no effect on the direction of LIFE Old i.e., LIFE Old and Lyra Therapeutics go up and down completely randomly.
Pair Corralation between LIFE Old and Lyra Therapeutics
Given the investment horizon of 90 days LIFE Old is expected to under-perform the Lyra Therapeutics. In addition to that, LIFE Old is 1.01 times more volatile than Lyra Therapeutics. It trades about -0.04 of its total potential returns per unit of risk. Lyra Therapeutics is currently generating about -0.03 per unit of volatility. If you would invest 275.00 in Lyra Therapeutics on October 11, 2024 and sell it today you would lose (255.00) from holding Lyra Therapeutics or give up 92.73% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 70.56% |
Values | Daily Returns |
LIFE Old vs. Lyra Therapeutics
Performance |
Timeline |
LIFE Old |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Lyra Therapeutics |
LIFE Old and Lyra Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with LIFE Old and Lyra Therapeutics
The main advantage of trading using opposite LIFE Old and Lyra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LIFE Old position performs unexpectedly, Lyra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyra Therapeutics will offset losses from the drop in Lyra Therapeutics' long position.LIFE Old vs. Mereo BioPharma Group | LIFE Old vs. Terns Pharmaceuticals | LIFE Old vs. PDS Biotechnology Corp | LIFE Old vs. Inozyme Pharma |
Lyra Therapeutics vs. CytomX Therapeutics | Lyra Therapeutics vs. Assembly Biosciences | Lyra Therapeutics vs. Achilles Therapeutics PLC | Lyra Therapeutics vs. Instil Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |